Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma
Status:
Withdrawn
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see how well electrochemotherapy works at treating people
with Stage III pancreatic adenocarcinoma. Electrochemotherapy is a treatment that combines
electroporation and chemotherapy administration. Electroporation uses an electric current to
produce holes in pancreatic tumor, which causes the tumor cells to die or take up a higher
concentration of administered chemotherapy agent. This study will test the safety and look at
the effect of electrochemotherapy in the treatment of stage III pancreatic adenocarcinoma.
This study will also help to find the safest and most effective amount of electroporation
voltage to apply to this type of tumor.
Phase:
Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston